119 related articles for article (PubMed ID: 7578513)
1. Interleukin, endotoxin, and tumor necrosis factor in CAPD dialysate.
Snitkoff G; Bailie GR; Eisele G
Perit Dial Int; 1995; 15(6):279-80. PubMed ID: 7578513
[No Abstract] [Full Text] [Related]
2. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis.
Brauner A; Hylander B; Wretlind B
Am J Kidney Dis; 1996 Mar; 27(3):402-8. PubMed ID: 8604710
[TBL] [Abstract][Full Text] [Related]
3. Determination of endotoxin levels and their impact on interleukin-1 generation in continuous ambulatory peritoneal dialysis and hemodialysis.
Pearson FC; Dubczak J; Weary M; Anderson J
Blood Purif; 1988; 6(3):207-12. PubMed ID: 3293624
[TBL] [Abstract][Full Text] [Related]
4. Potency of endotoxin from bicarbonate dialysate compared with endotoxins from Escherichia coli and Shigella flexneri.
Bland LA; Oliver JC; Arduino MJ; Oettinger CW; McAllister SK; Favero MS
J Am Soc Nephrol; 1995 Feb; 5(8):1634-7. PubMed ID: 7756598
[TBL] [Abstract][Full Text] [Related]
5. Does a high peritoneal transport rate reflect a state of chronic inflammation?
Wang T; Heimbürger O; Cheng HH; Bergström J; Lindholm B
Perit Dial Int; 1999; 19(1):17-22. PubMed ID: 10201336
[TBL] [Abstract][Full Text] [Related]
6. Appearance of tumor necrosis factor-alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPD.
Zemel D; Imholz AL; de Waart DR; Dinkla C; Struijk DG; Krediet RT
Kidney Int; 1994 Nov; 46(5):1422-30. PubMed ID: 7853803
[TBL] [Abstract][Full Text] [Related]
7. Complement in serum and dialysate in children on continuous ambulatory peritoneal dialysis.
Reddingius RE; Schröder CH; Daha MR; Willems HL; Koster AM; Monnens LA
Perit Dial Int; 1995; 15(1):49-53. PubMed ID: 7537541
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cytokine synthesis by peritoneal dialysate persists throughout the CAPD cycle.
Jörres A; Topley N; Steenweg L; Müller C; Köttgen E; Gahl GM
Am J Nephrol; 1992; 12(1-2):80-5. PubMed ID: 1415370
[TBL] [Abstract][Full Text] [Related]
9. Development of a stopped flow reactor for the rapid, high sensitivity measurement of endotoxin concentration in dialysate.
Miyasaka T; Iijima K; Sakai K; Yoshimi Y; Aketagawa J; Tamura H; Tanaka S
ASAIO J; 1999; 45(1):104-8. PubMed ID: 9952018
[TBL] [Abstract][Full Text] [Related]
10. Chronic and intradialytic effects of high-flux hemodialysis on tumor necrosis factor-alpha production: relationship to endotoxins.
Mege JL; Sanguedolce MV; Purgus R; Moulin B; Bongrand P; Capo C; Olmer M
Am J Kidney Dis; 1992 Nov; 20(5):482-8. PubMed ID: 1279968
[TBL] [Abstract][Full Text] [Related]
11. Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis?
Cueto-Manzano AM; Rojas-Campos E; Martínez-Ramírez HR; Valera-González I; Medina M; Monteón F; Ruiz N; Becerra M; Palomeque MA; Cortés-Sanabria L
Perit Dial Int; 2006; 26(3):341-8. PubMed ID: 16722027
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide binding protein: a marker for intraperitoneal bacterial infection in patients with CAPD peritonitis.
Schäfer K; Schumann RR; Stöteknuel S; Böhler J; Schollmeyer P; Dobos GJ
Adv Perit Dial; 1997; 13():210-3. PubMed ID: 9360683
[TBL] [Abstract][Full Text] [Related]
13. Interference in the Limulus amebocyte lysate assay for endotoxin determination in peritoneal dialysis fluids and concentrates for hemodialysis.
Bohrer D; Hörner R; do Nascimento PC; Adaime M; Pereira ME; Martins AF; Hartz SA
J Pharm Biomed Anal; 2001 Dec; 26(5-6):811-8. PubMed ID: 11600292
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of the endotoxin test for assessing CAPD peritonitis by gram-negative organisms.
Ishizaki M; Oikawa K; Miyashita E
Adv Perit Dial; 1996; 12():199-202. PubMed ID: 8865902
[TBL] [Abstract][Full Text] [Related]
15. Is the elimination of endotoxin and cytokines with continuous lavage an alternative procedure in necrotizing enterocolitis?
Birk D; Berger D; Limmer J; Beger HG
Acta Paediatr Suppl; 1994; 396():24-6. PubMed ID: 8086677
[TBL] [Abstract][Full Text] [Related]
16. Variations of cytokine levels and production in CAPD patients.
Serre AF; Marie C; Beaujon G; Betail G; Cavaillon JM; Deteix P
Int J Artif Organs; 1997 Nov; 20(11):614-21. PubMed ID: 9464871
[TBL] [Abstract][Full Text] [Related]
17. Detection of peptidoglycan and endotoxin in dialysate, using silkworm larvae plasma and limulus amebocyte lysate methods.
Tsuchida K; Takemoto Y; Yamagami S; Edney H; Niwa M; Tsuchiya M; Kishimoto T; Shaldon S
Nephron; 1997; 75(4):438-43. PubMed ID: 9127331
[TBL] [Abstract][Full Text] [Related]
18. Endotoxin size in hemodialysis solutions: modifications in presence of concentrated salt solutions and bacterial products.
Goury V; Steinmetz AC; Vincent F; Moufti A; Darbord JC
Adv Exp Med Biol; 1990; 256():685-9. PubMed ID: 2183572
[No Abstract] [Full Text] [Related]
19. Choline levels in human peritoneal dialysate.
Hjelle JT; Welch MH; Pavlina TM; Webb LE; Mockler D; Miller MA; Steidley KR; Olsson PJ; Horvath FJ; Mahon L
Adv Perit Dial; 1992; 8():30-2. PubMed ID: 1361811
[TBL] [Abstract][Full Text] [Related]
20. Proteoglycans of CAPD-dialysate fluid and mesothelium.
Davies M; Stylianou E; Yung S; Thomas GJ; Coles GA; Williams JD
Contrib Nephrol; 1990; 85():134-41. PubMed ID: 2078932
[No Abstract] [Full Text] [Related]
[Next] [New Search]
